We aimed to investigate the diagnostic efficacy of radiomics utilizing pre‐surgery contrast‐enhanced T1‐weighted imaging (CE‐T1WI) for predicting p53 status in IDH‐mt gliomas. This evidence concerns the gene TP53 and central nervous system cancer.